The 2025-2030 World Outlook for Defibrillators

The 2025-2030 World Outlook for Defibrillators

This study covers the world outlook for defibrillators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

In this report we define the sales of defibrillators as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott, Access Cardio Systems, ADS, Air Force, Alere, American Heart Association (AHA), Apama Medical, Inc., Asahi Kasei Corporation, Aska Equipments, Ltd., Augmenix, Inc., Aurora Capital Group, Aziyo, Badger State Sheriffs’ Association (BSSA), Barcelona City Council, Bavarian Red Cross, BIOTRONIC SE & Company, Biotronik, Boston Scientific, British Red Cross, Caisson Interventional, LLC., Cardiac Science, China Food and Drug Administration, Crospon, CU Medical System, Cyberonics, Defibtech, Department of Education, UK, European Heart Rhythm Association, Farong Shen in Zhejiang Lucheng Hospital, FUKUDA DENSHI, GE Healthcare, Groveland Fire Department, Health Canada, Heart Rhythm Society (HRS), ImThera Medical, Japanese Ministry of Health, Labour and Welfare, Johns Hopkins University, Koninklijke Philips, Lek, Life-Assist, Inc., Lippert Components, Inc., LivaNova, Mazor Robotics, Mediana, Medina, Medtronic, Metrax, METsis Medikal, MicroPort, Mindray DS, Mountain Rescue Association of Slovenia (MRAS), National Health Service, Nihon Kohden, Nutrino, nVision Medical Corporation, Philips, Physio-Control, Progetti Medical Equipment Solutions, Promega SRL., Quinton Cardiology Systems, Sand Holdco, Ltd., Saudi Heart Rhythm Society, Schiller, Securus Medical Group, Inc., Singapore Civil Defence Force (SCDF), Smith & Nephew, SORIN, Spacelabs Healthcare, St. Jude Medical, Stentor, Inc., Stryker, SYMETIS, TandemLife, The Spectranetics, United Nations, US Army, VisionSense, Walmart Canada, Wei Hua in Beijing Fuwai Hospital, Welch Allyn, World Health Organization, and Zoll Medical. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).